Key Dates

Related Announcements

NOT-HL-20-822 - Notice of Change of Receipt Date for RFA-HL-21-016 HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)

RFA-HL-20-015 - HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)

RFA-HL-20-016 - HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this notice is to inform interested applicants that there will be a change in receipt date for the Funding Opportunity Announcement (FOA) RFA-HL-21-015 "HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers (U01 Clinical Trial Not Allowed) . Specifically, the receipt date will change from December 7, 2020 to January 8, 2021. All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Vandana Sachdev, MD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-3015
Email: [email protected]

Peer Review Contact(s)

Director, Office of Scientific Review
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0270
Email: [email protected]

Financial/Grants Management Contact(s)

Annette Singletary
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8052
Email: [email protected]